53.7 F
San Diego
Thursday, Mar 28, 2024
-Advertisement-

Inovio Biomedical to Merge With East Coast Firm

Inovio Biomedical Corp., which developed a technology capable of delivering DNA vaccines into the body using brief electrical pulses, said July 7 that it will merge with privately held DNA vaccine maker VGX Pharmaceuticals of Pennsylvania.

Financial details of the reverse merger, which will allow VGX to go public, were not disclosed.

The merger, which is expected to close before the end of the year, will allow the companies to combine forces in DNA vaccines.

The majority of Inovio’s 50 workers are expected to remain with the company in San Diego, which will become a research and development site. The combined company, to be called VGX Pharmaceuticals, will be based in Blue Bell, Pa.

, Heather Chambers

-Advertisement-

Featured Articles

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-